Pfizer Inc 2021 SR
The report details Pfizer's 2021 ESG progress, highlighting its response to the COVID-19 pandemic through the delivery of over 1 billion vaccine doses to low- and middle-income countries. The company achieved a 7% reduction in Scope 1 and 2 greenhouse gas emissions from a 2019 baseline and issued its second Sustainability Bond for $1.0 billion. Pfizer also refreshed its Global Diversity, Equity, and Inclusion strategy, reaching 41.5% female representation at the VP level and above globally. Furthermore, the company integrated ESG metrics into its executive compensation structure and advanced its commitment to carbon neutrality by 2030.
Company: Pfizer Inc
Sector: Manufacturing
Country: United States
Year: 2021
Type: SR
Pages: 83
Pfizer Inc
The report details Pfizer's 2021 ESG progress, highlighting its response to the COVID-19 pandemic through the delivery of over 1 billion vaccine doses to low- and middle-income countries. The company achieved a 7% reduction in Scope 1 and 2 greenhouse gas emissions from a 2019 baseline and issued its second Sustainability Bond for $1.0 billion. Pfizer also refreshed its Global Diversity, Equity, and Inclusion strategy, reaching 41.5% female representation at the VP level and above globally. Furthermore, the company integrated ESG metrics into its executive compensation structure and advanced its commitment to carbon neutrality by 2030.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Jan 1, 2021 - Dec 31, 2021
Fiscal Year
2021
Published
Mar 17, 2022
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target
Employees